Formula (I) and the pharmaceutically acceptable salts and esters thereof, wherein X1, X2, X3,Y1, Y2 and R are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proiferative activity.
ARMSTRONG, DANIEL W.;LI, WEIYONG;STALCUP, APRYLL M.;SECOR, HENRY V.;IZAC,+, ANAL. CHIM. ACTA , 234,(1990) N, C. 365-380
作者:ARMSTRONG, DANIEL W.、LI, WEIYONG、STALCUP, APRYLL M.、SECOR, HENRY V.、IZAC,+
DOI:——
日期:——
Cis-imidazolines
申请人:Fotouhi Nader
公开号:US20060211693A1
公开(公告)日:2006-09-21
There are presented compounds of the formula
or pharmaceutically acceptable salts thereof,
wherein Y
1
, Y
2
, X
1
, X
2
, X
3
and R are as described in this application. These compounds are believed to inhibit MDM2-p53 interaction and as such the compounds will have anti-hyperproliferative cellular activity.